(Q38003641)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22515181%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

Interleukin-12: clinical usage and molecular markers of cancer susceptibility (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22515181%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22515181%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Arseniy E. Yuzhalin

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22515181%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Arseniy E Yuzhalin

series ordinal

1

1 reference

26 August 2017

19 April 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22515181%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

published in

Growth Factors Journal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22515181%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22515181%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22515181%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

176-191

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22515181%20AND%20SRC:MED&resulttype=core&format=json

IRF-4 functions as a tumor suppressor in early B-cell development

29 January 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Interleukin-10 therapy--review of a new approach

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

IL-21 stimulates human myeloma cell growth through an autocrine IGF-1 loop

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Association of IL-12p40 +1188 A/C polymorphism with nasopharyngeal cancer risk and tumor extension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

The interleukin-6 gene: a susceptibility factor that may contribute to racial and ethnic disparities in breast cancer mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Regulatory T cells in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Immunomodulation by fungal toxins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Interferon regulatory factor-1 (IRF-1) exhibits tumor suppressor activities in breast cancer associated with caspase activation and induction of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

IRF-1 promotes apoptosis in p53-damaged basal-type human mammary epithelial cells: a model for early basal-type mammary carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Multiple effects on peripheral hematology following administration of recombinant human interleukin 12 to nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Antitumor and antimetastatic activity of interleukin 12 against murine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Interactions of IL-12A and IL-12B polymorphisms on the risk of cervical cancer in Chinese women.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

IL-12p40 is associated with type 1 diabetes in Caucasian-American families.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Interleukin-12: biological properties and clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit interleukin-12 transcription by regulating nuclear factor kappaB and Ets activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

IL-21 contributes to JAK3/STAT3 activation and promotes cell growth in ALK-positive anaplastic large cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Increased risk of large-bowel cancer in Crohn's disease with colonic involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

IL-12 plays a significant role in the apoptosis of human T cells in the absence of antigenic stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Investigation of association of the IL12B and IL23R genes with psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

The epidemiology of non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Direct interaction of major histocompatibility complex class II-derived peptides with class Ia phosphoinositide 3-kinase results in dose-dependent stimulatory effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

SPPL2a and SPPL2b promote intramembrane proteolysis of TNFalpha in activated dendritic cells to trigger IL-12 production

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

The role of interferon in cancer therapy: a current perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Phase I trial of concurrent twice-weekly recombinant human interleukin-12 plus low-dose IL-2 in patients with melanoma or renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Interleukin-12 p40 gene (IL12B) polymorphisms and the risk of cervical cancer in Korean women.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Interleukin-21: updated review of Phase I and II clinical trials in metastatic renal cell carcinoma, metastatic melanoma and relapsed/refractory indolent non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Polymorphisms in Th1-type cell-mediated response genes and risk of gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

The roles of IFN gamma in protection against tumor development and cancer immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Interleukin 15 as a promising candidate for tumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Th1/Th2 cytokine expression and its relationship with tumor growth in B cell non-Hodgkin's lymphoma (NHL).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Interleukin 15-dependent crosstalk between conventional and plasmacytoid dendritic cells is essential for CpG-induced immune activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Polymorphisms within inflammatory genes and colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Polymorphisms in immunoregulatory genes, smoky coal exposure and lung cancer risk in Xuan Wei, China.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

IL12 polymorphisms, HBV infection and risk of hepatocellular carcinoma in a high-risk Chinese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Prophylactic human papillomavirus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Regulation of interleukin-12 production in antigen-presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Harnessing the biology of IL-7 for therapeutic application

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Regulation of interleukin-12 gene expression and its anti-tumor activities by prostaglandin E2 derived from mammary carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Evaluation of IL12B as a candidate type I diabetes susceptibility gene using data from the Type I Diabetes Genetics Consortium.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Targeted therapy for metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Randomized multicenter phase II trial of subcutaneous recombinant human interleukin-12 versus interferon-alpha 2a for patients with advanced renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

IL-12 + GM-CSF microsphere therapy induces eradication of advanced spontaneous tumors in her-2/neu transgenic mice but fails to achieve long-term cure due to the inability to maintain effector T-cell activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Interleukin 12 gene polymorphisms enhance gastric cancer risk in H pylori infected individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Effect of cytokine genotypes on the hepatitis B virus-hepatocellular carcinoma association

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Effect of interleukin 12 on tumor induction by 3-methylcholanthrene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Genetic polymorphisms in the cytokine genes and risk of hepatocellular carcinoma in low-risk non-Asians of USA

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

A phase I study of interleukin 12 with trastuzumab in patients with human epidermal growth factor receptor-2-overexpressing malignancies: analysis of sustained interferon gamma production in a subset of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

IRF4 is a suppressor of c-Myc induced B cell leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Immunization with Melan-A peptide-pulsed peripheral blood mononuclear cells plus recombinant human interleukin-12 induces clinical activity and T-cell responses in advanced melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Therapeutic effectiveness of intratumorally delivered dendritic cells engineered to express the pro-inflammatory cytokine, interleukin (IL)-32.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Genetic association of cytokine DNA polymorphisms with head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Gene-gene interactions between interleukin-12A and interleukin-12B with the risk of brain tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Signals through 4-1BB inhibit T regulatory cells by blocking IL-9 production enhancing antitumor responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Genetic associations with sporadic neuroendocrine tumor risk

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Inhibition of angiogenesis in vivo by interleukin 12.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

A phase II trial of interleukin-12 in patients with advanced cervical cancer: clinical and immunologic correlates. Eastern Cooperative Oncology Group study E1E96.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Expression and significance of intratumoral interleukin-12 and interleukin-18 in human gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Rapid release of cytoplasmic IL-15 from tumor-associated macrophages is an initial and critical event in IL-12-initiated tumor regression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Association of variants in the interleukin-27 and interleukin-12 gene with nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Environmental factors and risk for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

The role of interleukin DNA polymorphisms in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

A novel functional polymorphism, 16974 A/C, in the interleukin-12-3' untranslated region is associated with risk of glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Gut microbiota and probiotics in colon tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

A phase 2, randomized study of SB-485232, rhIL-18, in patients with previously untreated metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843

Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08977194.2012.678843